CJC-1295 With DAC 50 Vials – 30% Bulk Discount

Product Overview

CJC-1295 With DAC (Drug Affinity Complex) is a long-acting synthetic analogue of growth hormone-releasing hormone (GHRH), engineered to extend plasma half-life through covalent binding to endogenous albumin via its maleimidoproprionic acid (MPA) DAC linker. Revo Peptide offers this compound in a 50-vial bulk format at a 30% discount, making it one of the most cost-effective procurement options for qualified research institutions and licensed laboratory professionals sourcing high-purity GHRH analogues. Each vial contains 2 mg of lyophilized peptide, providing a total of 100 mg per bulk order. This listing represents an exceptional opportunity to buy CJC-1295 With DAC online at the best price without compromising on analytical quality.

Peptide Structure & Amino Acid Sequence

CJC-1295 With DAC is a 30-amino acid peptide derived from the first 29 residues of endogenous GHRH, with a C-terminal amide modification and an appended Drug Affinity Complex to facilitate albumin binding. The confirmed amino acid sequence is:

H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂

The inclusion of D-Ala at position 2 and the C-terminal amide group confers resistance to enzymatic degradation, while the DAC moiety dramatically prolongs circulating half-life compared to native GHRH. These structural features make CJC-1295 With DAC a widely studied subject in peptide pharmacokinetics research.

Chemical & Physical Characteristics

• Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• Molecular Weight: 3,367.79 g/mol
• Appearance: White lyophilized powder
• Solubility: Soluble in aqueous buffers; sterile water recommended for laboratory reconstitution
• Unit Size: 2 mg per vial
• Storage Conditions: –20°C (long-term); 2–8°C (short-term, up to 4 weeks)

Purity & Analytical Verification (HPLC & MS)

Every batch of CJC-1295 With DAC supplied by Revo Peptide undergoes rigorous third-party analytical testing prior to release. Purity is confirmed at ≥99% by reverse-phase high-performance liquid chromatography (RP-HPLC), and molecular identity is verified by electrospray ionization mass spectrometry (ESI-MS). Certificates of Analysis (CoA) are available upon request and reflect lot-specific data, ensuring full traceability for research documentation and institutional compliance requirements.

Quality Control & Lyophilization Integrity

CJC-1295 With DAC is lyophilized under controlled vacuum conditions to produce a stable, homogeneous white powder with minimal residual moisture. The lyophilization process preserves peptide integrity during extended storage and shipping, reducing the risk of degradation or aggregation. Each vial is sealed under inert atmosphere and inspected for particulate matter, seal integrity, and fill uniformity before dispatch. Revo Peptide’s quality control pipeline is designed to meet the expectations of professional research environments where batch-to-batch consistency is non-negotiable.

Safety, Handling & Laboratory Precautions

This compound is intended exclusively for in vitro and qualified laboratory research applications. Researchers should handle CJC-1295 With DAC in accordance with standard laboratory safety protocols, including the use of appropriate personal protective equipment (PPE) such as nitrile gloves, lab coat, and safety eyewear. Avoid inhalation of lyophilized powder during vial handling. All waste materials should be disposed of in compliance with applicable institutional biosafety and chemical waste regulations. This product has not been evaluated for safety or efficacy in humans or animals and must not be used outside a properly licensed research context.

Reconstitution, Packaging & Storage

Each vial of CJC-1295 With DAC is supplied as a lyophilized solid sealed under inert conditions. For laboratory reconstitution, sterile bacteriostatic water or an appropriate aqueous buffer is recommended. Reconstituted solutions should be stored at 2–8°C and used within a timeframe consistent with established peptide stability guidelines for the specific buffer system employed. Lyophilized vials should be stored at –20°C for long-term preservation. The 50-vial bulk format is packaged to ensure thermal stability and physical protection during transit, with each vial individually sealed and labeled with lot number and peptide identity.

Intended Research Use & Market Positioning

CJC-1295 With DAC is widely referenced in peer-reviewed literature examining GHRH receptor interactions, growth hormone secretagogue pharmacodynamics, and albumin-binding peptide engineering. It is a benchmark compound for researchers investigating long-acting GHRH analogues and is frequently used in comparative studies alongside other GH-axis modulators. The 50-vial bulk format at 30% off is specifically designed for research groups, contract research organizations (CROs), and academic laboratories requiring consistent, high-volume supply at a competitive price point. Revo Peptide positions this offering as a premium, compliance-ready research reagent for serious scientific procurement.

Ordering, Availability & Fulfillment

Order CJC-1295 With DAC online today through Revo Peptide and take advantage of the 30% bulk discount on this 50-vial configuration. Our fulfillment process is optimized for speed and discretion, with orders processed promptly and shipped with appropriate cold-chain packaging to preserve lyophilized peptide integrity in transit. Revo Peptide maintains consistent stock levels to support ongoing research programs without supply interruptions. For wholesale inquiries or volume orders exceeding this listing, contact our research sales team directly for custom pricing and fulfillment arrangements.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. CJC-1295 With DAC is sold exclusively as a laboratory research reagent. It has not been approved by the FDA or any equivalent regulatory authority for therapeutic, diagnostic, or prophylactic use. Purchasers are solely responsible for ensuring that acquisition, possession, and use of this compound complies with all applicable local, national, and international laws and regulations. Revo Peptide assumes no liability for misuse, improper handling, or use outside the scope of legitimate scientific research.